<h1>Nutraceutical Company Secures $3 Million Export Deal While Expanding into Diagnostics with Genome Testing Technology</h1> A BSE-listed nutraceutical company is expanding into the diagnostics sector, leveraging Genome Testing technology to enter India's diagnostics market projected to reach $25 billion by 2028. The company recently secured a $3 million export deal with a Singapore-based firm. Founded in 1989 with ISO certifications, the company aims to create integrated health solutions combining nutrition, diagnostics, and technology. With international expansion into Africa and Southeast Asia and product innovation, the company positions itself as an attractive investment opportunity in the integrated healthcare sector.